Last updated: 2026/02/17
Homepage
Last updated: 2026/02/17
Home
Areas of Focus
Cardiovascular metabolic system diseases
Central nervous system diseases
Skin diseases
Pipeline
Science & Innovation
News
Company Overview
Company News
Youngen Biotechnology｜Patent for Small Nucleic Acid Therapeutic Drugs for Alzheimer's Disease Granted
Enhance The Core Competitiveness of The Enterprise
Beijing Hotgen Subsidiary and Jinzhongmei Reached a Strategic Cooperation
Youngen Gene's Small Nucleic Acid Drug for the Treatment of Heart Failure has been Granted Patent
Youngen Attended the 1st Anniversary Event of Bayer Co.Lab in China
Meet in San Francisco | Youngen Biotechnology's Innovation Platform to Debut at the 2026 China FIC Innovation and Cooperation Global Summit
2026 JPM Spotlight Series | Youngen’s Innovation Marches Forward with the Official Launch of Kardia Shuttle™ RNA Therapeutics Cardiac-Targeted Delivery Platform Technology
Blog
All About the Central Nervous System
How Gene Therapy Can Cure or Treat Genetic Diseases
The Therapeutic Scope of Small Nucleic Acid Drugs
Small Nucleic Acid Drugs: Design Strategies and Application Prospects
Here is the translation: The Unique Advantages of Small Nucleic Acid Drugs
Immune-Mediated Therapy: A New Frontier in Biotech Introduction to Immune-Mediated Therapy
Strategies to Prevent Metabolism and Cardiovascular Diseases
Cardiac Metabolic: How Exercise Affects the Heart's Energy
Global Investment Trend: Overview of Small Nucleic Acid Drugs
The Progress of Research on Oligonucleotide Conjugates
RNAi Therapy: The Future of Precision Medicine
Contact
Last updated: 2026/02/17
Last updated: 2026/02/17
